Clinical Trial Update: Alendronate to Treat Polyostotic Fibrous Dysplasia and McCune-Albright Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update reports on using alendronate to treat polyostotic fibrous dysplasia and McCune-Albright syndrome, with the study status listed a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mccune-albright Syndrome
• Polyostotic Fibrous Dysplasia

Drugs mentioned

• alendronate (alendronate)

Snippet

Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) | Conditions: Polyostotic Fibrous Dysplasia | Phase 2 | Status: COMPLETED